Improving Study Activation Time for Gene Therapy Research
This blog explores how research sites are focusing on their institutional biosafety committee (IBC) programs as part of overall study activation time.
This blog explores how research sites are focusing on their institutional biosafety committee (IBC) programs as part of overall study activation time.
In clinical trials, the safety of research participants is paramount. An organization conducting or sponsoring clinical research can ensure participant
The study startup process is a critical point in research, and oftentimes, can make or break a study’s success.
In today’s world of research, using a clinical trial management system (CTMS) can significantly streamline operations, and make for a
Clinical research aims to produce knowledge in the service of treating diseases and improving human health. In a just and
IVDs diagnose and monitor health using biospecimens, often in labs. FDA-regulated but varied in compliance, IVDs require careful IRB review preparation.
Effective participant recruitment is crucial to a successful clinical trial, and as trials become more complex, the problem is intensifying.
The use of engineered genetic materials in clinical trials is rapidly expanding, with potential applications for genetic vaccines, gene-modified cellular
The Food and Drug Administration’s (FDA’s) proposed single institutional review board (sIRB) mandates are in part designed to support greater
Regulations for research involving devices, in vitro diagnostics (IVDs), and digital therapeutics differ from those governing pharmaceutical development. While drugs
The Food and Drug Administration (FDA) recently released new guidance regarding cellular and gene therapy products, one of which may
While regulatory management takes time and effort, using an eRegulatory system can help staff boost productivity, improve compliance, and save resources.